跳至主要内容
临床试验/NCT03421015
NCT03421015已完成不适用

Genomic Analysis in Localized or Locally Advanced Prostate Cancer. Identification of Biomarkers Predictive of Biochemical or Metastatic Recurrence

University Hospital, Lille2 个研究点 分布在 1 个国家目标入组 84 人开始时间: 2017年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
84
试验地点
2
主要终点
The genetic alteration frequencies of TMPRSS2-ERG gene fusion

研究概览

简要总结

Developing a genetic study on localized or locally advanced prostate cancer. The aim of the study is to identify genomic alteration predictive of metastatic recurrence in the context of primary heterogeneity, by using the next generation sequencing (NGS) techniques.

Identifying such biomarkers may be useful to detect a higher relapse risk, and thus lower the mortality rate.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients managed by radical prostatectomy for prostate cancer between 2000 and
  • Follow up > 6 years
  • Negative pre surgical extension assessment
  • Prognostic Grade Groups (OGG) III-IV-V
  • Biochemical recurrence defined by 2 consecutive PSA rises ≥ 0,2 ng/mL
  • Metastasis positive imaging

排除标准

  • Neoadjuvant therapy
  • Follow up < 6 years
  • Prognostic Grade Groups (PGG) I-II
  • Biochemical recurrence with metastasis negative imaging

结局指标

主要结局

The genetic alteration frequencies of TMPRSS2-ERG gene fusion

时间窗: Baseline

次要结局

  • Frequency of point mutations modifying protein function (SPOP)(Baseline)
  • Frequency of mutations or deletions of tumor suppressor genes (PTEN, TP53, NKX3-1),(Baseline)
  • Frequency of amplification of proto-oncogenes (MYC, AR, PIK3CA),(Baseline)

研究者

发起方
University Hospital, Lille
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验